Partners search for participation in Horizon Europe Cluster 1 Health and EU Mission Cancer calls
● Israel research institution Sheba Medical Center, having expertise in chemical exposome profiling, is searching for a consortium to join as a partner in a HE Cluster 1 topic:
- HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change.
Сontact person: Lauren Petrick, lauren.petrick@gmail.com
● The institute of Macromolecular Chemistry, Czech Academy of Science, is searching for a coordinator for consortia to participate in the topics:
- HORIZON-HLTH-2027-03-TOOL-02: Advancing Bio-Printing of Living Cells for Regenerative Medicine
- HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment.
Сontact person: Jana Dvořáková, dvorakova@imc.cas.cz
● The team of the department of thoracic surgery at the University hospital of Berne in Switzerland is looking for a consortium applying to:
- HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers.
Contact person: Michail Galanis, Michail.galanis@insel.ch
● Cerebro, a Belgian healthtech company developing a software platform that helps primary care teams manage chronic disease follow-up more proactively and efficiently, is looking for partners to work on a proposal for the following HE topics (2027):
- HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support
Contact person: Jeff Guns, info@cerebro-health.com
In the attached document you can find more information.
● Gesundheit Österreich GmbH is looking for partners for the following HE topics with the expertise to improve the quality of care of disabled people, patients with rare diseases and post-acute infection syndromes, patient safety:
- HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications.
Contact person: Nina Fehringer, nina.fehringer@goeg.at
Contact details are in the form.
● Canadan SME that specialises in the production of nano/microscale biopolymer fibers 3DBioFibR Inc is keen to find partners interested in the topics:
- HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine.
Contact person: Jonathan Krupski, jkrupski@3dbiofibr.com
● Skutocne zdrava skola (Really Healhty School), NGO that empowers schools to create a healthy and sustainable food culture, is looking for a consortium to join in the following Cluster 1 2027 topics:
- HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03
- HORIZON-HLTH-2027-01-STAYHLTH-01
- HORIZON-HLTH-2027-01-DISEASE-10.
Contact person: Monika Breckova, monika.breckova@cvtisr.sk
● Czech biotechnology ESSENCE LINE is searching for partners for HE call topic:
- HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications.
Contact: vojtech.vinduska@essenceline.cz
Details are here.
● A techbio startup using AI-powered predictive modeling to evaluate drug side effects of chemical compounds Cytocast (Hungary) is looking for partners to participate in several HE calls from the list.
Contact person: Istvan Bagyi, business@cytocast.com
● French company Owl Lifesciences is searching partners for the HE calls:
- HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses.
Contact person: Antoni Homs Corbera, antoni.homs@owl-lifesciences.com
● Maltese SME RetroGradient Labs, specialising in applied research and development of trustworthy, production-grade artificial intelligence, is seeking collaboration opportunities in upcoming HE calls.
Contact person: Natalia Malliam, natalia@retrogradientlabs.com